News
AI Summary
11 Aug 202628 Safar 1448 AH
🔬The BioAI Phase Shift - Matthew McPartlon & Neil Patil, Chai Discovery

🔬The BioAI Phase Shift - Matthew McPartlon & Neil Patil, Chai Discovery

In January, four major AI tools deals in the pharma sector were announced at the JPM conference in San Francisco. OpenAI-backed Chai Discovery was at the center of these deals, now valued at $4 billion despite being only two years old. The JPM conference is a significant annual event for pharma deal-making, attracting numerous companies to discuss partnerships and innovations. Recently, firms developing AI tools for pharma have started building their own drug pipelines, indicating a shift in how these tools are utilized.

Follow these topics

Sign in to follow the topics that matter to you

Sign in to follow

This summary is generated with AI and receives periodic editorial review. Refer to the original source for full details.

0
0 reading now

Insight Score

Rate to unlock

Sign in to react, rate, and save. Sign In